通过诱导线粒体功能障碍和染色体重塑,SLC25A3促进肝细胞癌的进展
Shuangya Deng1,2, Jie Fu2
1Department of General Surgery, Guilin Hospital of the Second Xiangya Hospital, Central South University, Guilin, China.
Translational cancer research
|January 9, 2026
概括
溶性载体家族25成员A3 (SLC25A3) 在肝细胞癌 (HCC) 中过度表达,通过影响线粒体功能促进癌症生长. 准SLC25A3可能为HCC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 目前对晚期HCC的治疗方法提供了不令人满意的结果,需要新的治疗点.
- 溶解体载体家族25成员A3 (SLC25A3) 正在研究其在HCC中的作用.
研究的目的:
- 阐明SLC25A3在肝细胞癌中的作用和机制.
- 确定SLC25A3作为HCC的潜在治疗点.
主要方法:
- 对癌症基因组图谱 (TCGA) 数据库对HCC中线粒体基因表达的分析.
- 在临床HCC样本中检查SLC25A3表达.
- 在体内和体外实验中评估SLC25A3功能.
- 多omics测序来调查潜在的机制.
主要成果:
- 在HCC中,SLC25A3显著过度表达,并与预后不佳有关.
- SLC25A3促进肝癌发生,可能是通过线粒体功能障碍.
- 多omics数据表明,SLC25A3调节了HCC中的线粒体功能和染色质重塑.
结论:
- 在肝细胞癌中,SLC25A3具有致癌作用.
- SLC25A3代表了HCC的潜在治疗标.
- 了解SLC25A3机制为新型HCC疗法提供了洞察力.
相关概念视频
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K


